Table 1.
Characteristics of patients from whom pancreatic samples were obtained at surgery. n/a, data not available.
| Gender | Age (years) | BMI at RYGB | BMI at Pancreatic Surgery | Pathology |
|---|---|---|---|---|
| CONTROLS (no RYGB) | ||||
| F | 28 | – | 18 | Microcystic serous cystadenoma |
| F | 38 | – | 25.1 | Leiomyoma, normal pancreas |
| n/a | n/a | – | n/a | Localized pancreatic tumor |
| M | 69 | – | n/a | Serous cystadenoma |
| M | 65 | – | n/a | Intraductal papillary mucinous adenoma |
| F | 43 | – | n/a | Ampullary adenoma, normal pancreas |
| POST-RYGB NEUROGLYCOPENIC HYPOGLYCEMIA | ||||
| M | 46 | 40.6 | 23.1 | Islet hyperplasia |
| F | 42 | n/a | 30 | Islet hyperplasia |
| F | 35 | 42.3 | 37.5 | Islet hyperplasia |
| F | 37 | n/a | n/a | Islet hyperplasia |
| F | 29 | 46.8 | 26.3 | Islet hyperplasia |
| F | 33 | 40 | 25.8 | Islet hyperplasia |
| F | 49 | 43.5 | 29.7 | Islet hyperplasia |
| F | 69 | n/a | n/a | Islet hyperplasia |
| n/a | n/a | n/a | n/a | Islet hyperplasia |
| F | 54 | n/a | n/a | Islet hyperplasia |
| F | 36 | n/a | n/a | Islet hyperplasia |
| n/a | n/a | n/a | n/a | Islet hyperplasia |